{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:26:56Z","timestamp":1793636816281,"version":"4.5.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.jpsychires.2026.10.023","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:33:29Z","timestamp":1792424009000},"page":"219-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Psilocybin for anhedonia in unipolar and bipolar depression: A systematic review of clinical and preclinical evidence"],"prefix":"10.1016","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5170-0265","authenticated-orcid":false,"given":"Erica S.","family":"Kaczmarek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0928-3433","authenticated-orcid":false,"given":"Sabrina","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3325-5854","authenticated-orcid":false,"given":"Noah","family":"Chisamore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5669-7036","authenticated-orcid":false,"given":"Maya","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0140-8994","authenticated-orcid":false,"given":"Zoe","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2000-7691","authenticated-orcid":false,"given":"Danica E.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4773-2191","authenticated-orcid":false,"given":"Joshua D.","family":"Rosenblat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2026.10.023_bib1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jamapsychiatry.2023.4685","article-title":"Single-dose synthetic psilocybin with psychotherapy for treatment-resistant bipolar type II major depressive episodes: a nonrandomized open-label trial","volume":"81","author":"Aaronson","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders, DSM-5-TR","year":"2022"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fpsyt.2019.00017","article-title":"The efficacy of vortioxetine on anhedonia in patients with major depressive disorder","volume":"10","author":"Cao","year":"2019","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pnpbp.2019.01.002","article-title":"Pharmacological interventions targeting anhedonia in patients with major depressive disorder: a systematic review","volume":"92","author":"Cao","year":"2019","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s40501-024-00319-8","article-title":"Neurobiology of the antidepressant effects of serotonergic psychedelics: a narrative review","volume":"11","author":"Chisamore","year":"2024","journal-title":"Curr. Treat Option. Psych."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cobeha.2018.01.024","article-title":"Anhedonia in depression: biological mechanisms and computational models","volume":"22","author":"Cooper","year":"2018","journal-title":"Curr. Opin. Behav. Sci."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0006-8993(00)02062-X","article-title":"Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area","volume":"864","author":"Doherty","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41398-025-03421-4","article-title":"Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress","volume":"15","author":"Erkizia-Santamar\u00eda","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib10","article-title":"The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice","author":"Fleury","year":"2025","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/ijnp\/pyac074","article-title":"Default mode network modulation by psychedelics: a systematic review","volume":"26","author":"Gattuso","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177304","article-title":"Mice lacking the serotonin transporter do not respond to the behavioural effects of psilocybin","volume":"991","author":"Gattuso","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib13","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1080\/14737175.2020.1826931","article-title":"The emerging role of psilocybin and MDMA in the treatment of mental illness","volume":"20","author":"Gill","year":"2020","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jpsychires.2022.12.024","article-title":"Evaluating anhedonia as a risk factor in suicidality: a meta-analysis","volume":"158","author":"Gillissie","year":"2023","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib15","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib16","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1192\/j.eurpsy.2023.273","article-title":"Improvement in depression symptoms measured by montgomery-\u00e5sberg depression rating scale and quick inventory of depressive symptomatology-self rated items after randomised double-blind COMP360 psilocybin therapy for treatment-resistant depression","volume":"66","author":"Goodwin","year":"2023","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jad.2017.05.048","article-title":"Emotional blunting with antidepressant treatments: a survey among depressed patients","volume":"221","author":"Goodwin","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115531","article-title":"Psilocybin-assisted therapy for depression: a systematic review and meta-analysis","volume":"329","author":"Haikazian","year":"2023","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib19","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1038\/s41380-025-03035-8","article-title":"Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises","volume":"30","author":"Harding","year":"2025","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib20","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.640241","article-title":"Low doses of psilocybin and ketamine enhance motivation and attention in poor performing rats: evidence for an antidepressant property","volume":"12","author":"Higgins","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2026.121385","article-title":"Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression","volume":"403","author":"Kaczmarek","year":"2026","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyaf048","article-title":"Association between anhedonia severity and clinical, humanistic, and economic outcomes among US adults with major depressive disorder","volume":"28","author":"Kale","year":"2025","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.105","article-title":"Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression","volume":"4","author":"Lally","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyae055","article-title":"Anhedonia is associated with a specific depression profile and poor antidepressant response","volume":"27","author":"Luca","year":"2024","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/wps.20771","article-title":"The clinical characterization of the adult patient with depression aimed at personalization of management","volume":"19","author":"Maj","year":"2020","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib29","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3390\/brainsci12101287","article-title":"Sucrose preference test as a measure of anhedonic behavior in a chronic unpredictable mild stress model of depression: outstanding issues","volume":"12","author":"Markov","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/03007995.2023.2178082","article-title":"Long-term safety and efficacy, including anhedonia, of vortioxetine for major depressive disorder: findings from two open-label studies","volume":"39","author":"Mattingly","year":"2023","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib31","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.cmet.2017.04.033","article-title":"A guide for the design of pre-clinical studies on sex differences in metabolism","volume":"25","author":"Mauvais-Jarvis","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib32","first-page":"21","article-title":"Psychedelics for the treatment of psychiatric disorders: interpreting and translating available evidence and guidance for future research","volume":"182","author":"McIntyre","year":"2025","journal-title":"Aust. J. Pharm."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib33","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jad.2024.07.070","article-title":"Minimal clinically important change in the MADRS anhedonia factor score: a pooled analysis of open-label studies with vortioxetine in patients with major depressive disorder","volume":"363","author":"McIntyre","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib34","article-title":"Psilocybin-assisted psychotherapy for treatment-resistant depression in bipolar II disorder","author":"Meshkat","year":"2024","journal-title":"Psyched. Med. Psymed."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib35","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neubiorev.2015.01.019","article-title":"Reward functioning in PTSD: a systematic review exploring the mechanisms underlying anhedonia","volume":"51","author":"Nawijn","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib37","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s00213-022-06105-9","article-title":"The effect of ketamine on anhedonia: improvements in dimensions of anticipatory, consummatory, and motivation-related reward deficits","volume":"239","author":"Nogo","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib38","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"n71","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib39","first-page":"458","article-title":"Toward a better understanding of the mechanisms and pathophysiology of anhedonia: are we ready for translation?","volume":"179","author":"Pizzagalli","year":"2022","journal-title":"Aust. J. Pharm."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1192\/bjp.bp.108.051110","article-title":"Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study","volume":"195","author":"Price","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib41","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.euroneuro.2023.08.496","article-title":"Sucrose preference test: a systematic review of protocols for the assessment of anhedonia in rodents","volume":"77","author":"Primo","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib42","article-title":"Esketamine and psilocybin\u2014the comparison of two mind-altering agents in depression treatment: systematic review","volume":"23","author":"Psiuk","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neubiorev.2016.03.004","article-title":"Assessing anhedonia in depression: potentials and pitfalls","volume":"65","author":"Rizvi","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.psychres.2015.07.062","article-title":"Development and validation of the dimensional anhedonia rating scale (DARS) in a community sample and individuals with major depression","volume":"229","author":"Rizvi","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/07067437221111371","article-title":"The Canadian network for mood and anxiety treatments (CANMAT) task force report: serotonergic psychedelic treatments for major depressive disorder","volume":"68","author":"Rosenblat","year":"2023","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib46","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.medj.2024.01.005","article-title":"Psilocybin-assisted psychotherapy for treatment resistant depression: a randomized clinical trial evaluating repeated doses of psilocybin","volume":"5","author":"Rosenblat","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib47","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41398-025-03611-0","article-title":"Psychedelic compounds directly excite 5-HT2A layer V medial prefrontal cortex neurons through 5-HT2A Gq activation","volume":"15","author":"Schmitz","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib48","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqae083","article-title":"Potential differences in psychedelic actions based on biological sex","volume":"165","author":"Shadani","year":"2024","journal-title":"Endocrinology"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib49","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib50","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/02698811221125354","article-title":"Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression","volume":"37","author":"Shukuroglou","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-024-07624-5","article-title":"Psilocybin desynchronizes the human brain","volume":"632","author":"Siegel","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1192\/bjp.167.1.99","article-title":"A scale for the assessment of Hedonic tone the snaith\u2013hamilton pleasure scale","volume":"167","author":"Snaith","year":"1995","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib53","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"i4919","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib54","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00213-017-4754-y","article-title":"Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression","volume":"235","author":"Stroud","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib55","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s43440-024-00660-y","article-title":"Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases","volume":"76","author":"Szpr\u0119giel","year":"2024","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.120836","article-title":"The effect of dextromethorphan on reward-related behaviors: a systematic review of preclinical and clinical evidence","volume":"398","author":"Teopiz","year":"2026","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.727117","article-title":"Psychedelics and other psychoplastogens for treating mental illness","volume":"12","author":"Vargas","year":"2021","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib58","article-title":"Anhedonia as a central factor in depression: neural mechanisms revealed from preclinical to clinical evidence","volume":"110","author":"Wang","year":"2021","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib59","article-title":"Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed wistar rats","volume":"136","author":"Wang","year":"2025","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.10.023_bib60","series-title":"Anhedonia: Preclinical, Translational, and Clinical Integration, Current Topics in Behavioral Neurosciences","first-page":"111","article-title":"Anhedonia in depression and bipolar disorder","author":"Whitton","year":"2022"},{"key":"10.1016\/j.jpsychires.2026.10.023_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1322752","article-title":"Short-term ketamine use in bipolar depression: a review of the evidence for short-term treatment management","volume":"14","author":"Wilkowska","year":"2023","journal-title":"Front. Psychiatr."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626005054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626005054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:42:23Z","timestamp":1793634143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395626005054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":61,"alternative-id":["S0022395626005054"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.10.023","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psilocybin for anhedonia in unipolar and bipolar depression: A systematic review of clinical and preclinical evidence","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}